Lisle, Il., February 7, 2025 — Anju Software is proud to announce that TA Scan’s Feasibility Flex, has been named a 2025 SCOPE Best of Show Award winner. Recognized by industry professionals at the annual SCOPE Summit, this award celebrates breakthrough innovations that enhance clinical trial operations and feasibility assessments.
With over 60 new product finalists on display in the Exhibit Hall and more than 300 SCOPE attendees voting, the Best of Show Awards spotlight the most impactful solutions shaping the future of clinical research. Anju Software’s Feasibility Flex Module stood out for its ability to transform clinical trial planning by refining enrollment forecasts through a powerful combination of clinical intelligence and real-world operational data.
Revolutionizing Clinical Trial Feasibility with Data-Driven Insights
TA Scan’s Feasibility Flex is designed to tackle one of the biggest challenges in clinical trial execution—accurate feasibility and enrollment forecasting. By leveraging high-quality clinical trial data and allowing customizable inputs, the module enables clinical teams to:
✔ Generate more precise enrollment projections by integrating real-world operational data with site and country-level trial insights.
✔ Optimize trial feasibility assessments by simulating real-time scenarios based on key parameters such as country selection, regulatory delays, and patient distribution.
✔ Improve site and investigator selection by assessing competitive trial landscapes and identifying sites with the capacity to recruit effectively.
✔ Reduce trial delays and inefficiencies by providing actionable insights that help match expectations with reality in the feasibility planning process.
“Our TA Scan Feasibility Flex Module is redefining trial planning by combining high-quality data with flexible, user-driven insights,” said Greg Flett-Davies, Senior Director of Business Development at Anju Software. “As the only solution of its kind, it enables clinical teams to make data-backed feasibility decisions with confidence. We are honored to be recognized at SCOPE for the second consecutive year, reinforcing our commitment to advancing clinical trial technology.”
Join the Future of Clinical Trial Feasibility
Anju Software extends its gratitude to SCOPE attendees, industry peers, and the voting community for this recognition. Anju remains committed to delivering cutting-edge solutions that drive efficiency, accuracy, and innovation in clinical research.
About Anju Software
Anju Software is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science. TrialMaster, IRMS MAX, and TA Scan, the company’s flagship products, lead the way in reducing complexities in the drug and device discovery and commercialization process. Anju is a portfolio company of Valsoft Corporation serving the worldwide pharmaceutical, biotech and contract research Life Sciences markets.